Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 03 04:00PM ET
2.07
Dollar change
-0.25
Percentage change
-10.78
%
IndexRUT P/E- EPS (ttm)-2.40 Insider Own19.50% Shs Outstand96.69M Perf Week1.97%
Market Cap200.15M Forward P/E- EPS next Y-1.50 Insider Trans4.25% Shs Float77.83M Perf Month-29.83%
Income-212.15M PEG- EPS next Q-0.43 Inst Own55.42% Short Float4.07% Perf Quarter-25.54%
Sales70.72M P/S2.83 EPS this Y42.06% Inst Trans9.92% Short Ratio8.22 Perf Half Y-40.86%
Book/sh-1.78 P/B- EPS next Y12.04% ROA-52.00% Short Interest3.16M Perf Year86.49%
Cash/sh2.84 P/C0.73 EPS next 5Y- ROE-705.53% 52W Range0.94 - 6.04 Perf YTD24.70%
Dividend Est.- P/FCF- EPS past 5Y84.52% ROI- 52W High-65.73% Beta1.53
Dividend TTM- Quick Ratio4.68 Sales past 5Y91.46% Gross Margin91.81% 52W Low119.98% ATR (14)0.22
Dividend Ex-Date- Current Ratio4.92 EPS Y/Y TTM-9.33% Oper. Margin-193.15% RSI (14)36.05 Volatility11.26% 9.76%
Employees162 Debt/Eq- Sales Y/Y TTM-42.30% Profit Margin-300.00% Recom1.33 Target Price8.50
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q27.82% Payout- Rel Volume1.12 Prev Close2.32
Sales Surprise0.17% EPS Surprise-6.33% Sales Q/Q27.40% EarningsNov 07 BMO Avg Volume385.19K Price2.07
SMA20-16.04% SMA50-26.45% SMA200-41.35% Trades Volume431,865 Change-10.78%
Date Action Analyst Rating Change Price Target Change
Nov-08-24Initiated Stephens Overweight $6
May-30-24Initiated Cantor Fitzgerald Overweight
Mar-28-24Initiated Guggenheim Buy $11
Aug-10-23Upgrade JP Morgan Underweight → Neutral
Apr-24-23Downgrade BofA Securities Neutral → Underperform $7 → $2
Dec-06-22Initiated CapitalOne Overweight $12
Nov-09-22Downgrade BofA Securities Buy → Neutral $14 → $7
Sep-21-22Initiated JP Morgan Overweight $5
Sep-09-22Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $11
Nov-09-21Initiated Wolfe Research Outperform $44
Dec-02-24 04:30PM
Nov-14-24 02:02AM
Nov-08-24 01:14PM
Nov-07-24 08:50AM
07:30AM
07:41AM Loading…
Nov-06-24 07:41AM
Nov-05-24 09:47AM
Nov-04-24 07:15AM
Nov-01-24 04:05PM
09:40AM
Oct-31-24 07:15AM
Oct-01-24 04:05PM
Sep-03-24 04:05PM
07:15AM
Aug-06-24 08:40AM
07:30AM Loading…
07:30AM
Aug-01-24 04:05PM
Jul-30-24 07:15AM
Jul-11-24 03:24PM
Jul-08-24 02:00AM
Jul-01-24 04:05PM
Jun-27-24 07:15AM
Jun-13-24 02:31PM
Jun-03-24 04:05PM
May-30-24 07:15AM
May-15-24 07:15AM
May-09-24 07:01PM
07:15AM
May-07-24 08:55AM
08:44AM
10:53AM Loading…
May-06-24 10:53AM
08:22AM
07:30AM
07:20AM
06:55AM
06:10AM
06:00AM
May-01-24 04:05PM
07:00AM
Apr-16-24 08:30AM
Apr-04-24 07:00AM
Apr-03-24 07:00AM
Apr-01-24 04:05PM
Mar-15-24 12:30PM
Mar-14-24 05:16AM
Mar-13-24 08:51AM
08:20AM
07:00AM
Mar-06-24 07:15AM
07:00AM
Mar-05-24 05:45PM
Feb-27-24 07:00AM
Feb-20-24 10:00AM
Feb-16-24 03:57AM
Feb-15-24 11:57AM
Feb-08-24 01:15PM
Jan-19-24 01:05PM
09:40AM
Jan-04-24 10:05AM
07:15AM
07:00AM
Dec-12-23 05:15AM
Nov-20-23 02:40AM
Nov-15-23 03:00AM
Nov-08-23 01:26PM
01:03AM
Nov-07-23 08:15AM
07:15AM
07:00AM
Nov-06-23 07:00AM
Nov-02-23 05:50PM
10:10AM
Nov-01-23 10:01AM
Oct-31-23 10:01AM
Oct-24-23 07:00AM
Oct-04-23 04:00AM
Sep-05-23 07:00AM
Aug-30-23 07:33PM
Aug-14-23 10:51AM
Aug-11-23 10:53AM
Aug-10-23 10:31AM
Aug-09-23 12:09PM
Aug-08-23 11:01PM
10:48AM
08:15AM
07:00AM
Aug-07-23 05:25PM
Aug-04-23 08:40AM
08:12AM
Aug-03-23 11:48AM
11:45AM
08:02AM
Aug-02-23 12:45PM
12:42PM
Aug-01-23 10:45AM
07:22AM
07:00AM
Jul-28-23 08:02AM
Jul-26-23 08:52AM
Jul-24-23 01:20PM
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Redmile Group, LLC10% OwnerJul 01 '24Buy2.81400,0001,124,00015,669,217Jul 03 08:00 PM
Redmile Group, LLC10% OwnerJul 01 '24Buy2.81400,0001,124,00012,995,040Jul 03 08:00 PM
Azelby RobertDirectorJun 17 '24Sale2.896,99520,21653,005Jun 18 09:45 PM
BIZZARI JEAN-PIERREDirectorJun 17 '24Sale2.896,99520,21679,502Jun 18 09:43 PM
Hug PeterDirectorJun 17 '24Sale2.891,1933,448182,644Jun 18 09:41 PM
Monges VivianeDirectorJun 17 '24Sale2.891,4374,153106,627Jun 18 09:40 PM
Pfisterer ThomasDirectorJun 17 '24Sale2.891,4374,153213,900Jun 18 09:38 PM
Sandor VictorDirectorJun 17 '24Sale2.896,99520,21680,886Jun 18 09:37 PM
Squarer RonDirectorJun 17 '24Sale2.896,99520,21680,663Jun 18 09:35 PM
MALLIK AMEETChief Executive OfficerMay 07 '24Sale4.4829,731133,1951,167,348May 09 04:06 PM